Quantum computing platform beats AI in drug discovery, study claims

Quantum computing could be used to find candidate molecules with more speed and success than GenAI.

Credit: gorodenkoff/Shutterstock

A new study claims that a drug discovery software platform using D-Wave's Advantage system could reduce the time in selecting pre-clinical molecular candidates faster than GenAI and other classical alternatives

Register for FREE to keep reading

Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:

Insights into HPC, AI, lab informatics & data
Curated content for life sciences, engineering & academia
Access to Breakthroughs: real-world computing success
Free reports & panels, including the Lab Informatics Guide
White Papers & software updates for smarter research

Sign up now

Already a member? Log in here

Your data is protected under our privacy policy.

Where hype meets reality: why breakthrough computing technologies must prove their scientific worth

High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modeling, and materials science. But how do we ensure billion-dollar investments in advanced computing infrastructure deliver tangible scientific value?